RxSight, Inc.
RXSTNasdaqHealthcare · Ophthalmic Goods · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $134.5M | $139.9M | $89.1M | $49.0M | $22.6M | $14.7M |
| Operating income | −$48.2M | −$36.9M | −$50.1M | −$63.3M | −$52.8M | −$35.4M |
| Net income | −$38.9M | −$27.5M | −$48.6M | −$66.8M | −$48.7M | $27.6M |
| Total assets | $311.8M | $318.6M | $182.6M | $150.2M | $192.7M | $100.7M |
| Total liabilities | $36.1M | $37.3M | $22.2M | $60.3M | $54.5M | $44.9M |
| Equity | $275.7M | $281.2M | $160.4M | $89.9M | $138.2M | −$430.6M |
| EPS (diluted) | $-0.95 | $-0.71 | $-1.41 | $-2.41 | $-3.57 | $0.15 |
| Shares out. | 40.5M | 37.0M | 33.8M | 27.4M | 27.4M | 5.5M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −35.8%
- Net margin
- −29.0%
- Return on equity
- −14.1%
- Return on assets
- −12.5%
- Return on capital (ROCE)
- −16.9%
- Liabilities / assets
- 11.6%
- Debt / equity
- 0.13×
- Book value / share
- $6.81
- Revenue growth (YoY)
- −3.9%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 5.56safe
- Accruals / assets
- −7.5%clean
- Beneish M-Score
- -3.12normal
- Piotroski F-Score
- 2/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 4 warning● 3 good- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- Negative operating cash flow
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Artisan Partners Limited PartnershipPassive (13G)May 13, 2026
- Vanguard Group IncPassive (13G)Mar 27, 2026
- Ra Capital Management, L.P.Passive (13G)Nov 14, 2025
- Millennium Management LlcPassive (13G)Nov 4, 2025
- Blackrock, Inc.Passive (13G)Oct 17, 2025
- Divisadero Street Capital Management, LpPassive (13G)Aug 13, 2025
- Bank Of America Corp /De/Passive (13G)Aug 13, 2025
- Lord, Abbett & Co. LlcPassive (13G)Feb 13, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 4.9M | 6.0 | -12.9% |
| Apr 30, 2026 | 5.6M | 9.6 | -0.0% |
| Apr 15, 2026 | 5.6M | 8.2 | +10.1% |
| Mar 31, 2026 | 5.1M | 6.3 | -0.1% |
| Mar 13, 2026 | 5.1M | 7.1 | -8.4% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operationsMay 6, 2026
- Results of operationsFeb 25, 2026
- Results of operations · Director / officer change · Regulation FD disclosureJan 12, 2026
- Director / officer change · Regulation FD disclosureDec 23, 2025
- Director / officer change · Regulation FD disclosureDec 22, 2025
- Director / officer changeDec 19, 2025
- Results of operationsNov 5, 2025
- Results of operationsAug 7, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.